Targeting of the AKT/m-TOR Pathway: Biomarkers of Resistance to Cancer Therapy——
AKT/m-TOR Pathway and Resistance to Cancer Therapy

Targeting of the AKT/m-TOR Pathway: Biomarkers of Resistance to Cancer Therapy——
AKT/m-TOR Pathway and Resistance to Cancer Therapy

Resistance to cancer therapy continues to be a major limitation for the successful treatment of cancer. There are many published studies on therapy resistance in breast and prostate cancers; however, there are currently no data on molecular markers associated with resistance. The conflicting data we...

Full description

Bibliographic Details
Main Authors: Liudmila V SPIRINA, Irina V KONDAKOVA, Natalia V TARASENKO, Elena M SLONIMSKAYA, Evgeny A USYNIN, Alexey K GORBUNOV, Zahar A YURMAZOV, Svetlana Yu CHIGEVSKAYA
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2018-01-01
Series:Chinese Journal of Lung Cancer
Subjects:
AKT/m-TOR signaling pathway
Resistance to cancer therapy
Molecular markers
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2018.01.09

Internet

http://dx.doi.org/10.3779/j.issn.1009-3419.2018.01.09

Similar Items